While there is no cure for mesothelioma, many patients undergo treatment following diagnosis to improve their survival rate. The most popular treatment options utilized by mesothelioma patients include surgery, chemotherapy and radiation therapy. Other forms of experimental treatment currently include photodynamic therapy, gene therapy and immunotherapy.
Researchers Klerk and Musk found that “Various treatments have been tried, including chemotherapy, radiation and surgery… Some of these may lead to temporary improvement in quality of life, and also an apparent increase in survival; however, groups of patients for whom increased survival has been described after various mesothelioma treatments are generally specially selected for treatment and are likely to have survived longer anyway. No treatments have yet been described that would justify Phase 3 trials.”
Mesothelioma patients are increasingly being treated with cancer management therapies since there is no cure for this cancer. For example, a mesothelioma patient diagnosed in the first or second stage of the cancer who responds favorably to surgery may undergo radiation therapy or further surgeries to manage growth and metastasis of the cancer.
Many patients also find hope to improve their survival through participation in a clinical trial. Clinical trials are conducted to test up-and-coming treatments and medications before they are deemed safe and effective for the general public. This allows mesothelioma patients to receive treatment and contribute to the growing body of mesothelioma research that could eventually lead
The type of mesothelioma, whether pleural, peritoneal, pericardial or testicular, can affect survival time. According to “Asbestos: Risk Assessment, Epidemiology, and Health Effects,” researchers Ribak and Selikoff “reported a mean time of 11.4 months from presentation until death for pleural mesothelioma and 7.4 months for peritoneal mesothelioma in 457 consecutive fatal cases of mesothelioma in asbestos insulation workers.”
Researchers Klerk and Musk found that “Various treatments have been tried, including chemotherapy, radiation and surgery… Some of these may lead to temporary improvement in quality of life, and also an apparent increase in survival; however, groups of patients for whom increased survival has been described after various mesothelioma treatments are generally specially selected for treatment and are likely to have survived longer anyway. No treatments have yet been described that would justify Phase 3 trials.”
Mesothelioma patients are increasingly being treated with cancer management therapies since there is no cure for this cancer. For example, a mesothelioma patient diagnosed in the first or second stage of the cancer who responds favorably to surgery may undergo radiation therapy or further surgeries to manage growth and metastasis of the cancer.
Many patients also find hope to improve their survival through participation in a clinical trial. Clinical trials are conducted to test up-and-coming treatments and medications before they are deemed safe and effective for the general public. This allows mesothelioma patients to receive treatment and contribute to the growing body of mesothelioma research that could eventually lead
The type of mesothelioma, whether pleural, peritoneal, pericardial or testicular, can affect survival time. According to “Asbestos: Risk Assessment, Epidemiology, and Health Effects,” researchers Ribak and Selikoff “reported a mean time of 11.4 months from presentation until death for pleural mesothelioma and 7.4 months for peritoneal mesothelioma in 457 consecutive fatal cases of mesothelioma in asbestos insulation workers.”
No comments:
Post a Comment